Similar articles

• Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.

  Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J. Lintzeris N, et al. Drug Alcohol Depend. 2007 Dec 1;91(2-3):187-94. doi: 10.1016/j.drugalcdep.2007.05.019. Epub 2007 Jul 12. Drug Alcohol Depend. 2007. PMID: 17624687 Clinical Trial.
• Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.

  McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM. McCance-Katz EF, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S235-46. doi: 10.1086/508188. Clin Infect Dis. 2006. PMID: 17109310
• Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.

  Dykstra LA. Dykstra LA. J Pharmacol Exp Ther. 1983 Aug;226(2):317-23. J Pharmacol Exp Ther. 1983. PMID: 6875844
• Pharmacokinetic interactions between buprenorphine and antiretroviral medications.

  Bruce RD, McCance-Katz E, Kharasch ED, Moody DE, Morse GD. Bruce RD, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S216-23. doi: 10.1086/508186. Clin Infect Dis. 2006. PMID: 17109308 Review.
• Office-based buprenorphine treatment for opioid-dependent patients.

  McCance-Katz EF. McCance-Katz EF. Harv Rev Psychiatry. 2004 Nov-Dec;12(6):321-38. doi: 10.1080/10673220490905688. Harv Rev Psychiatry. 2004. PMID: 15764468 Review.